An advertised price with no drug attached to it
The AgelessRx GLP-1 landing page shows a starting-at figure with footnotes about plan lengths. It does not say what medication that figure buys.
Walking the intake answers it. The product screen is headed as personalized compounded semaglutide with glycine. That is several screens after the price that brought you in.
A price you cannot attach to a product is not a price you can compare. Anyone putting that landing-page figure next to a named compounded rate elsewhere is guessing at what is on the other side of it.
The price depends on which link you arrived through
The low semaglutide figure is a first-month price on a four-month plan paid up front in full. It also depends on a coupon the marketing site attaches to the intake link.
Enter the same intake without that coupon string and the same product screen shows a substantially higher starting figure. Same drug, same plan, two prices, decided by a URL.
Tirzepatide runs the other direction. The plain intake shows one starting figure and the coupon link shows a lower one. So the discount is real, and which way it points depends on the product.
Before you commit, confirm the standing rate after the first month and the total charged today. A first-month discount on a four-month prepayment is a small share of what you are actually agreeing to pay.
Access & Monitoring is a product name, not a scope
AgelessRx sells three brand-name products under the Access & Monitoring label. Each carries a starting-at figure on the weight management page.
The name describes access and monitoring. The site does not state whether the medication itself is included in the figure.
With brand-name GLP-1s, that is not a detail. Cash prices for these drugs run into four figures, so whether the drug is inside or outside the number is most of the decision. Get it in writing before buying.
Eden, by contrast, publishes brand-name cash figures for four products with the scope stated. That is the comparison to make here.
Nobody's name is on it
No legal entity name is published anywhere on the AgelessRx site. Not in the Terms and Conditions, not in the Privacy Policy, not in the footer.
That is unusual even in a field with thin disclosure. Most sellers in this comparison at least name a company in their terms, because the terms are a contract and a contract has parties.
The entity is who you would be buying from, who you would complain to, and who a state board or a regulator would write to. Willow publishes its company and street address. Eden names its operating entity in its terms.
This is the one gap here that no amount of price shopping compensates for. Ask for the company name before you pay anything.
What it does say clearly
The intake states the compounding step plainly, saying the product is tested for potency and quality by a US-licensed pharmacy. The disclaimer says the FDA has not reviewed or approved compounded products for safety, efficacy or quality.
AgelessRx also publishes separate lower-dose microdosing programs for both compounds, each with its own figure. Those are a different product from the full-dose plans and should not be read as a cheaper version of the same thing.
No pharmacy is named. The site refers to US-licensed, LegitScript-certified pharmacy partners, which is a category rather than an identity.
AgelessRx's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $139/moThe GLP-1 landing page shows "Starting at" "$139" "/ mo" with the footnotes "Monthly, 2-mo, and 4-mo plans" and "Starting price applies to 4-mo plan" and does not name the drug. Walking the intake with dummy data identified it: the product screen is headed "Personalized Compounded Semaglutide + Glycine" and shows "$239" struck through to "$139" with "Save" "$100" "/ first month*" and the footnote "*First month price for a 4 month plan paid up front in full." Entering the same intake without the coupon string the marketing site attaches, the same screen reads "Starting at $239". | September 2026source |
| Tirzepatide (compounded) | $349/moThe intake's treatment-choice screen lists "Tirzepatide" "Dual-action GLP-1 + GIP" "Starting at $349/mo". The product screen calls it "Compounded Tirzepatide + Glycine" at "Starting at $349"; entering through the coupon link the marketing site uses, the same card reads "Starting at $279". | September 2026source |
| Semaglutide (compounded) | $99/mo"Microdosing Semaglutide" — "Starting at" "$99" "/ mo". A separate lower-dose program, not the full-dose plan. | September 2026source |
| Tirzepatide (compounded) | $159/mo"Microdosing Tirzepatide" — "Starting at" "$159" "/ mo". A separate lower-dose program, not the full-dose plan. | September 2026source |
| Semaglutide (brand) | $199/mo"Wegovy® Pill Access & Monitoring" — "Starting at" "$199" "/ mo". The product is named "Access & Monitoring"; the site does not state whether the drug itself is included in this figure. | September 2026source |
| Semaglutide (brand) | $264/mo"Wegovy® Access & Monitoring" — "Starting at" "$264" "/ mo". The intake confirms the same figure: "Great news, you qualify for Wegovy® Access & Monitoring! Start your journey for as little as $264/mo." The product is named "Access & Monitoring"; the site does not state whether the drug itself is included. | September 2026source |
| Tirzepatide (brand) | $364/mo"Zepbound® Access & Monitoring" — "Starting at" "$364" "/ mo". The product is named "Access & Monitoring"; the site does not state whether the drug itself is included. | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 38 providers reviewed here are paid partners today; the other 34 are not. See how this works.
See AgelessRx's current price →Good fit if
- Readers who want compounded and brand-name options on the same site and will press for what each figure covers.
- Patients interested in a lower-dose microdosing program priced separately from a full-dose plan.
- People willing to prepay four months to get the lowest advertised rate on compounded semaglutide.
- Readers who want a seller that states in plain words that the FDA has not approved compounded products.
Look elsewhere if
- Anyone who wants to know which company they are buying from. AgelessRx publishes no legal entity name anywhere on its site; Willow publishes its company and street address.
- Readers who need a price that does not change with the link they clicked.
- Patients buying a brand-name GLP-1 who need to know whether the drug is included. Eden publishes brand-name cash figures with the scope stated.
- Anyone who needs the compounding pharmacy named. Willow names five with addresses; Belle Health names more than one.
How this review was verified
- Walked the AgelessRx intake with dummy data, because the GLP-1 landing page advertises a figure without naming the drug it applies to.
- Logged the product screen's own heading, which identifies the advertised plan as compounded semaglutide with glycine, and recorded the figure with the date it was read.
- Entered the same intake twice, once through the coupon link the marketing site attaches and once without it, and recorded both figures with the URL each was read at.
- Did the same for tirzepatide and recorded that the coupon link and the plain intake disagree in the opposite direction.
- Carried the plan length and the up-front prepayment into the semaglutide qualifier, so a first-month rate cannot be read as a standing monthly rate.
- Read the Terms and Conditions, the Privacy Policy and the site footer for an operating entity name. None of the three names one.
- Recorded the brand-name products under the Access and Monitoring label exactly as the site names them, and noted that the site does not state whether the drug is included.